FDA finds low levels of cancer-linked impurity in common heartburn drugs
2019-09-16
The US Food and Drug Administration said Friday it has learned some ranitidine — acid-reducing and heartburn medicines, including those known by the brand name Zantac — contain low levels of an impurity that could cause cancer. The nitrosamine impurity known as N-nitrosodimethylamine or NDMA has been classified as a probable human carcinogenContinue Reading